Metabolic benefits of oral polymer-based duodenal exclusion therapyGlyscend Therapeutics has presented preclinical study results at EASD 2021 evaluating the metabolic effects of once-daily oral therapy in...
LSG and RYGB-induced upregulation of apoA-IV is beneficial for insulin secretion and energy expenditure1 day ago
Tirzepatide reduced sleep apnoea severity by up to nearly two-thirds in adults living with OSA and obesity1 day ago